Evan Guillemin Net Worth

The estimated Net Worth of Evan Guillemin is at least $11.2 millió dollars as of 1 September 2022. Mr. Guillemin owns over 431 units of Mesa Laboratories stock worth over $3,492,281 and over the last 15 years he sold MLAB stock worth over $7,550,351. In addition, he makes $174,871 as Independent Director at Mesa Laboratories.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Guillemin MLAB stock SEC Form 4 insiders trading

Evan has made over 25 trades of the Mesa Laboratories stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 431 units of MLAB stock worth $51,535 on 1 September 2022.

The largest trade he's ever made was buying 40,000 units of Mesa Laboratories stock on 21 December 2010 worth over $990,000. On average, Evan trades about 3,446 units every 110 days since 2009. As of 1 September 2022 he still owns at least 29,207 units of Mesa Laboratories stock.

You can see the complete history of Mr. Guillemin stock trades at the bottom of the page.

Evan Guillemin biography

Evan C. Guillemin serves as Independent Director of the Company. Mr. Guillemin has served as Chief Financial Officer (“CFO”) and Associate Portfolio Manager at Select Equity Group Inc., a registered investment adviser based in New York City, since 2004. Mr. Guillemin also currently serves on the Board of Directors of Shake Shack, Inc. (NYSE: SHAK), and a privately held company. Prior to joining Select Equity Group, Mr. Guillemin served as CFO of Alloy Merchandising Group Inc., the successor to Delias Inc. Mr. Guillemin was an executive and board member of Delias Inc., a Nasdaq-traded specialty retailing company. He served as CFO and then Chief Operating Officer of Delias from 1996 to 2003, when the company was acquired by Alloy Inc. He received his Bachelor of Arts degree from Yale University in 1987 and a Master of Business Administration degree with distinction from Harvard Business School in 1996.

What is the salary of Evan Guillemin?

As the Independent Director of Mesa Laboratories, the total compensation of Evan Guillemin at Mesa Laboratories is $174,871. There are 9 executives at Mesa Laboratories getting paid more, with Gary Owens having the highest compensation of $3,485,970.

How old is Evan Guillemin?

Evan Guillemin is 54, he's been the Independent Director of Mesa Laboratories since 2009. There are 6 older and 8 younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories, Inc. is David Kelly, 78, who is the Independent Director.

What's Evan Guillemin's mailing address?

Evan's mailing address filed with the SEC is 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK, NY, 10003.

Insiders trading at Mesa Laboratories

Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny és John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.

What does Mesa Laboratories do?

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers

Complete history of Mr. Guillemin stock trades at Mesa Laboratories és Shake Shack Inc

Mesa Laboratories executives and stock owners

Mesa Laboratories executives and other stock owners filed with the SEC include:

• Gary Owens,
  President, Chief Executive Officer, Director
• John Sakys,
  Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
• Greg DiNoia,
  Senior Vice President - Commercial Operations
• Gary M. Owens,
  CEO, Pres & Director
• Brian Archbold,
  Senior Vice President - Continuous Improvement
• Brian David Archbold,
  Sr. VP of Continuous Improvement
• John V. Sakys,
  CFO & Chief Accounting Officer
• Gregory T. DiNoia,
  Sr. VP of Commercial Operations
• John Sullivan,
  Chairman of the Board
• John Schmieder,
  Independent Director
• David Kelly,
  Independent Director
• Evan Guillemin,
  Independent Director
• Jennifer Alltoft,
  Independent Director
• Shannon Hall,
  Director
• Peter M. Dansky,
  Pres of Clinical Genomics
• Garrett Krushefski,
  Sr. VP of Operations
• Bryan T. Leo,
  Sr. VP of Operations
• Gina Hinman Trulli,
  VP of HR
• Elizabeth Karpinski Vonne,
  VP of Legal, Gen. Counsel & Sec.
• Robert Bradley,
  Sr. Director of Operations
• Michael T Brooks,
  Director
• H Stuart Campbell,
  Director
• Ventures, Llc Seg,
  Director
• Luke R Schmieder,
  President CEO Treasurer
• Paul D Duke,
  Director
• Michael Tranmer,
  Executive Vice President
• Glenn E Adriance,
  VP Sales and Marketing
• Steven W Peterson,
  VP Finance, CFO, Secretary
• Robert V Dwyer,
  Director
• David Brian Perez,
  Director
• Mark Christopher Capone,
  Director
• Shiraz Shabanali Ladiwala,
  Director
• Laboratories Inc /Co/ Mesa,
  Director
• R Tony Tripeny,
  Director